BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12804425)

  • 1. Methylxanthines for exacerbations of chronic obstructive pulmonary disease.
    Barr RG; Rowe BH; Camargo CA
    Cochrane Database Syst Rev; 2003; (2):CD002168. PubMed ID: 12804425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl-xanthines for exacerbations of chronic obstructive pulmonary disease.
    Barr RG; Rowe BH; Camargo CA
    Cochrane Database Syst Rev; 2001; 2003(1):CD002168. PubMed ID: 11279755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials.
    Barr RG; Rowe BH; Camargo CA
    BMJ; 2003 Sep; 327(7416):643. PubMed ID: 14500434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled tiotropium for stable chronic obstructive pulmonary disease.
    Barr RG; Bourbeau J; Camargo CA; Ram FS
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002876. PubMed ID: 15846642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous versus intermittent beta-agonists in the treatment of acute asthma.
    Camargo CA; Spooner CH; Rowe BH
    Cochrane Database Syst Rev; 2003; 2003(4):CD001115. PubMed ID: 14583926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma.
    Travers AH; Jones AP; Camargo CA; Milan SJ; Rowe BH
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010256. PubMed ID: 23235686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beclometasone for chronic obstructive pulmonary disease.
    De Coster DA; Jones M; Thakrar N
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009769. PubMed ID: 24105424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma.
    Parameswaran K; Belda J; Rowe BH
    Cochrane Database Syst Rev; 2000; (4):CD002742. PubMed ID: 11034753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Chong J; Leung B; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD002309. PubMed ID: 24190161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
    Sestini P; Renzoni E; Robinson S; Poole P; Ram FS
    Cochrane Database Syst Rev; 2002; (4):CD001495. PubMed ID: 12519559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
    Yang IA; Fong KM; Sim EH; Black PN; Lasserson TJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD002991. PubMed ID: 17443520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD.
    van Geffen WH; Douma WR; Slebos DJ; Kerstjens HA
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011826. PubMed ID: 27569680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Wang W; Morley C; Soltani A; Wood-Baker R
    Cochrane Database Syst Rev; 2011 Oct; (10):CD006897. PubMed ID: 21975757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Appleton S; Smith B; Veale A; Bara A
    Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S; Evans DJ; Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral theophylline for chronic obstructive pulmonary disease.
    Ram FS; Jones PW; Castro AA; De Brito JA; Atallah AN; Lacasse Y; Mazzini R; Goldstein R; Cendon S
    Cochrane Database Syst Rev; 2002; 2002(4):CD003902. PubMed ID: 12519617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.